Skip to main content
Top
Published in: Journal of Hematology & Oncology 1/2022

Open Access 01-12-2022 | Pediatric Cancer | Correction

Correction to: COVID-19 in pediatric cancer patients is associated with treatment interruptions but not with short-term mortality: a Polish national study

Authors: Jadwiga Węcławek-Tompol, Zuzanna Zakrzewska, Olga Gryniewicz-Kwiatkowska, Filip Pierlejewski, Ewa Bień, Agnieszka Zaucha-Prażmo, Olga Zając-Spychała, Anna Szmydki-Baran, Agnieszka Mizia-Malarz, Wioletta Bal, Małgorzata Sawicka-Żukowska, Agnieszka Kruk, Tomasz Ociepa, Anna Raciborska, Agnieszka Książek, Tomasz Szczepański, Jarosław Peregud-Pogorzelski, Maryna Krawczuk-Rybak, Radosław Chaber, Michał Matysiak, Jacek Wachowiak, Ninela Irga-Jaworska, Wojciech Młynarski, Bożenna Dembowska-Bagińska, Walentyna Balwierz, Agnieszka Matkowska-Kocjan, Bernarda Kazanowska, Jan Styczyński, Marek Ussowicz

Published in: Journal of Hematology & Oncology | Issue 1/2022

Login to get access

Excerpt

The original article [1] mistakenly omitted two co-authors—Tomasz Ociepa and Ninela Irga-Jaworska—who have both since been re-instated into the authorship. …
Metadata
Title
Correction to: COVID-19 in pediatric cancer patients is associated with treatment interruptions but not with short-term mortality: a Polish national study
Authors
Jadwiga Węcławek-Tompol
Zuzanna Zakrzewska
Olga Gryniewicz-Kwiatkowska
Filip Pierlejewski
Ewa Bień
Agnieszka Zaucha-Prażmo
Olga Zając-Spychała
Anna Szmydki-Baran
Agnieszka Mizia-Malarz
Wioletta Bal
Małgorzata Sawicka-Żukowska
Agnieszka Kruk
Tomasz Ociepa
Anna Raciborska
Agnieszka Książek
Tomasz Szczepański
Jarosław Peregud-Pogorzelski
Maryna Krawczuk-Rybak
Radosław Chaber
Michał Matysiak
Jacek Wachowiak
Ninela Irga-Jaworska
Wojciech Młynarski
Bożenna Dembowska-Bagińska
Walentyna Balwierz
Agnieszka Matkowska-Kocjan
Bernarda Kazanowska
Jan Styczyński
Marek Ussowicz
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Journal of Hematology & Oncology / Issue 1/2022
Electronic ISSN: 1756-8722
DOI
https://doi.org/10.1186/s13045-022-01279-3

Other articles of this Issue 1/2022

Journal of Hematology & Oncology 1/2022 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine